Safe 6-thioguanine therapy of a TPMT deficient Crohn's disease patient by using therapeutic drug monitoring

Pearson, 1995, Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis, Ann Intern Med, 123, 132, 10.7326/0003-4819-123-2-199507150-00009 Adler, 1990, The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis, Am J Gastroenterol, 85, 717 Dubinsky, 2000, Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease, Gastroenterology, 118, 705, 10.1016/S0016-5085(00)70140-5 Lennard, 1989, Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism, Clin Pharmacol Ther, 46, 149, 10.1038/clpt.1989.119 Sandborn, 2001, Rational dosing of azathioprine and 6-mercaptopurine, Gut, 48, 591, 10.1136/gut.48.5.591 Dubinsky, 2001, An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy, Inflamm Bowel Dis, 7, 181, 10.1097/00054725-200108000-00001 Derijks, 2004, Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy, Ther Drug Monit, 26, 311, 10.1097/00007691-200406000-00016 Gilissen, 2004, Therapeutic drug monitoring in patients with inflammatory bowel disease and established azathioprine therapy, Clin Drug Investig, 24, 479, 10.2165/00044011-200424080-00006 Cuffari, 2001, Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease, Gut, 48, 642, 10.1136/gut.48.5.642 Lennard, 2002, TPMT in the treatment of Crohn's disease with azathioprine, Gut, 51, 143, 10.1136/gut.51.2.143 Kaskas, 2003, Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine, Gut, 52, 140, 10.1136/gut.52.1.140 Derijks, 2003, 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment, Eur J Gastroenterol Hepatol, 15, 63, 10.1097/00042737-200301000-00011 Herrlinger, 2003, 6-thioguanine—efficacy and safety in chronic active Crohn's disease, Aliment Pharmacol Ther, 17, 503, 10.1046/j.1365-2036.2003.01440.x Dubinsky, 2003, Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine, Am J Gastroenterol, 98, 1058, 10.1111/j.1572-0241.2003.07413.x de Boer, 2005, On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients, World J Gastroenterol, 11, 5540, 10.3748/wjg.v11.i35.5540 Gilissen, 2007, Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?, Dig Liver Dis, 39, 156, 10.1016/j.dld.2006.10.007